- Home
- GNTA vs HBIO Comparison
GNTA vs HBIO Comparison
Compare GNTA & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTA
- HBIO
- Stock Information
- Founded
- GNTA 2014
- HBIO 1901
- Country
- GNTA Italy
- HBIO United States
- Employees
- GNTA N/A
- HBIO N/A
- Industry
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- GNTA Health Care
- HBIO Industrials
- Exchange
- GNTA Nasdaq
- HBIO Nasdaq
- Market Cap
- GNTA 96.0M
- HBIO 93.3M
- IPO Year
- GNTA 2021
- HBIO 2000
- Fundamental
- Price
- GNTA $5.01
- HBIO $2.11
- Analyst Decision
- GNTA Strong Buy
- HBIO
- Analyst Count
- GNTA 1
- HBIO 0
- Target Price
- GNTA $25.00
- HBIO N/A
- AVG Volume (30 Days)
- GNTA 5.8K
- HBIO 175.7K
- Earning Date
- GNTA 01-01-0001
- HBIO 11-07-2024
- Dividend Yield
- GNTA N/A
- HBIO N/A
- EPS Growth
- GNTA N/A
- HBIO N/A
- EPS
- GNTA N/A
- HBIO N/A
- Revenue
- GNTA N/A
- HBIO $97,732,000.00
- Revenue This Year
- GNTA N/A
- HBIO N/A
- Revenue Next Year
- GNTA N/A
- HBIO $4.32
- P/E Ratio
- GNTA N/A
- HBIO N/A
- Revenue Growth
- GNTA N/A
- HBIO N/A
- 52 Week Low
- GNTA $2.20
- HBIO $1.99
- 52 Week High
- GNTA $7.28
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- GNTA 47.05
- HBIO 43.18
- Support Level
- GNTA $4.95
- HBIO $2.01
- Resistance Level
- GNTA $5.50
- HBIO $2.23
- Average True Range (ATR)
- GNTA 0.27
- HBIO 0.13
- MACD
- GNTA -0.01
- HBIO -0.01
- Stochastic Oscillator
- GNTA 45.56
- HBIO 27.03
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.